D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Genetics D-index 60 Citations 11,316 183 World Ranking 2369 National Ranking 11

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • DNA
  • Mutation

His scientific interests lie mostly in microRNA, Neuroblastoma, Cancer research, Genetics and Gene expression. Raymond L. Stallings combines topics linked to Gene silencing with his work on microRNA. Raymond L. Stallings interconnects Hippocampal formation, Status epilepticus and Neuroprotection in the investigation of issues within Gene silencing.

His Neuroblastoma study integrates concerns from other disciplines, such as Cancer, Pediatric cancer, Cellular differentiation, MicroRNA 34a and Regulation of gene expression. His work deals with themes such as Molecular biology, Transcription factor, N-Myc Proto-Oncogene Protein and Gene expression profiling, which intersect with Regulation of gene expression. His Cancer research study incorporates themes from Signal transduction and Pathology.

His most cited work include:

  • MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. (674 citations)
  • Evolution and distribution of (GT)n repetitive sequences in mammalian genomes (338 citations)
  • Differential Patterns of MicroRNA Expression in Neuroblastoma Are Correlated with Prognosis, Differentiation, and Apoptosis (324 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of investigation include Neuroblastoma, Genetics, Cancer research, microRNA and Molecular biology. His Neuroblastoma study combines topics from a wide range of disciplines, such as Cancer, Pediatric cancer, DNA methylation, Bioinformatics and Transcription factor. His Cancer research study also includes fields such as

  • Epilepsy most often made with reference to Pathology,
  • Apoptosis which intersects with area such as Cisplatin.

His microRNA research includes elements of Cell, Gene expression, Cellular differentiation, Regulation of gene expression and Gene silencing. The Gene silencing study combines topics in areas such as Status epilepticus and Neuroprotection. In his study, Cell growth and In vivo is inextricably linked to Cell culture, which falls within the broad field of Molecular biology.

He most often published in these fields:

  • Neuroblastoma (65.11%)
  • Genetics (48.94%)
  • Cancer research (47.66%)

What were the highlights of his more recent work (between 2011-2021)?

  • Neuroblastoma (65.11%)
  • Cancer research (47.66%)
  • microRNA (44.68%)

In recent papers he was focusing on the following fields of study:

Raymond L. Stallings mainly investigates Neuroblastoma, Cancer research, microRNA, Molecular biology and DNA methylation. His Neuroblastoma study is concerned with the field of Genetics as a whole. The various areas that Raymond L. Stallings examines in his Cancer research study include Promoter, Gene expression, Signal transduction, Phosphorylation and Epigenetics.

He interconnects Viability assay, Cell, Cell culture, Cellular differentiation and Pathology in the investigation of issues within microRNA. His study in Molecular biology is interdisciplinary in nature, drawing from both Gene expression profiling, Carcinogenesis, Transcription factor, Oncogene and Gene silencing. His DNA methylation research integrates issues from Methylation and Massive parallel sequencing.

Between 2011 and 2021, his most popular works were:

  • Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressive effects (323 citations)
  • Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressive effects (323 citations)
  • LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression (255 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • DNA
  • Mutation

His main research concerns Neuroblastoma, microRNA, Cancer research, Epilepsy and Molecular biology. His Neuroblastoma study combines topics from a wide range of disciplines, such as Epithelial–mesenchymal transition and Cisplatin. His microRNA research incorporates themes from Apoptosis, Cell and Downregulation and upregulation.

Raymond L. Stallings combines subjects such as DNA methylation, Pathology, Signal transduction, Regulation of gene expression and Epigenetics with his study of Cancer research. His studies in Epilepsy integrate themes in fields like Hippocampus and Gene expression. His Molecular biology research is multidisciplinary, incorporating perspectives in Viability assay and Gene silencing.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells.

C Welch;Y Chen;R L Stallings.
Oncogene (2007)

981 Citations

Evolution and distribution of (GT)n repetitive sequences in mammalian genomes

R.L. Stallings;A.F. Ford;D. Nelson;D.C. Torney.
Genomics (1991)

551 Citations

Differential Patterns of MicroRNA Expression in Neuroblastoma Are Correlated with Prognosis, Differentiation, and Apoptosis

Yongxin Chen;Raymond L. Stallings.
Cancer Research (2007)

446 Citations

Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressive effects

Eva M Jimenez-Mateos;Tobias Engel;Paula Merino-Serrais;Ross C McKiernan.
Nature Medicine (2012)

440 Citations

LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression

Jan J Molenaar;Raquel Domingo-Fernández;Marli E Ebus;Sven Lindner.
Nature Genetics (2012)

340 Citations

Analysis of chromosome breakpoints in neuroblastoma at sub‐kilobase resolution using fine‐tiling oligonucleotide array CGH

Rebecca R. Selzer;Todd A. Richmond;Nathan J. Pofahl;Roland D. Green.
Genes, Chromosomes and Cancer (2005)

311 Citations

Rare deletions at 16p13.11 predispose to a diverse spectrum of sporadic epilepsy syndromes.

Erin L. Heinzen;Rodney A. Radtke;Thomas J. Urban;Gianpiero L. Cavalleri.
American Journal of Human Genetics (2010)

277 Citations

Human metallothionein genes: structure of the functional locus at 16q13.

A.K. West;R. Stallings;C.E. Hildebrand;R. Chiu.
Genomics (1990)

254 Citations

Inhibition of neuroblastoma tumor growth by targeted delivery of microRNA-34a using anti-disialoganglioside GD2 coated nanoparticles.

Amanda Tivnan;Amanda Tivnan;Wayne Shannon Orr;Wayne Shannon Orr;Vladimir Gubala;Robert Nooney.
PLOS ONE (2012)

232 Citations

miR-126 Is Downregulated in Cystic Fibrosis Airway Epithelial Cells and Regulates TOM1 Expression

Irene K. Oglesby;Isabella M. Bray;Sanjay H. Chotirmall;Raymond L. Stallings.
Journal of Immunology (2010)

217 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Raymond L. Stallings

David C. Henshall

David C. Henshall

Royal College of Surgeons in Ireland

Publications: 78

Jo Vandesompele

Jo Vandesompele

Ghent University

Publications: 54

Evan E. Eichler

Evan E. Eichler

University of Washington

Publications: 53

Johannes H. Schulte

Johannes H. Schulte

Charité - University Medicine Berlin

Publications: 47

John M. Maris

John M. Maris

Children's Hospital of Philadelphia

Publications: 42

Franki Speleman

Franki Speleman

Ghent University

Publications: 38

Matthias Fischer

Matthias Fischer

University of Cologne

Publications: 35

Tobias Engel

Tobias Engel

Royal College of Surgeons in Ireland

Publications: 33

Rogier Versteeg

Rogier Versteeg

University of Amsterdam

Publications: 32

Olivier Delattre

Olivier Delattre

PSL University

Publications: 30

Norman Delanty

Norman Delanty

Beaumont Hospital

Publications: 29

Frank Westermann

Frank Westermann

German Cancer Research Center

Publications: 28

Jan Koster

Jan Koster

University of Amsterdam

Publications: 28

Catherine M. Greene

Catherine M. Greene

Royal College of Surgeons in Ireland

Publications: 28

Felix Rosenow

Felix Rosenow

Goethe University Frankfurt

Publications: 27

Heather C. Mefford

Heather C. Mefford

University of Washington

Publications: 26

Trending Scientists

Alexandre Gramfort

Alexandre Gramfort

University of Paris-Saclay

Kevin Crowston

Kevin Crowston

Syracuse University

Beata Smarzynska Javorcik

Beata Smarzynska Javorcik

University of Oxford

Andrew Tomkins

Andrew Tomkins

Google (United States)

Sheldon H. Jacobson

Sheldon H. Jacobson

University of Illinois at Urbana-Champaign

Liesbet Geris

Liesbet Geris

University of Liège

Mohammad Asif

Mohammad Asif

King Saud University

Bryan S. Pivovar

Bryan S. Pivovar

National Renewable Energy Laboratory

Clifford George

Clifford George

United States Naval Research Laboratory

Enzo Terreno

Enzo Terreno

University of Turin

Robert G. Martin

Robert G. Martin

National Institutes of Health

Jürg Böni

Jürg Böni

University of Zurich

Thomas W. Dubensky

Thomas W. Dubensky

Tempest Therapeutics

Zhi-Li Huang

Zhi-Li Huang

Fudan University

Bianca Weinstock-Guttman

Bianca Weinstock-Guttman

University at Buffalo, State University of New York

Brian J. L. Berry

Brian J. L. Berry

The University of Texas at Dallas

Something went wrong. Please try again later.